Literature DB >> 2105884

Murine lambda gene rearrangements: the stochastic model prevails over the ordered model.

B Nadel1, P A Cazenave, P Sanchez.   

Abstract

The ontogeny of the immunoglobulin (Ig) gene rearrangement in mammalian B cells seems to be ordered. Heavy chain gene segments rearrange first, followed by light chain gene segments, kappa before lambda. The genomic organization of murine lambda locus does not preclude the simultaneous expression of two subtypes from the same chromosome. In order to distinguish between an ordered and a stochastic model of rearrangement, a panel of 67 B cell hybridomas secreting either lambda 1, lambda 2, lambda 3 or lambda x (recently described) were analysed for V lambda J lambda rearrangements. The results show that in 97% of cases, a single rearrangement occurred, favouring the stochastic model over the ordered one. Strikingly, the possibility of having a productive rearrangement if the first try results in an aberrant one is rare. We propose therefore, that the lambda Ig is not necessarily required to ensure allelic and subtypic exclusion mechanisms. Moreover, in 97% of the cases, at least one kappa allele is rearranged. Furthermore, the RS recombination has been detected in 77% of the cases. This suggests that, although the stimulation of kappa precedes that of lambda locus, the RS recombination acts as a transacting albeit dispensable lambda activator.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2105884      PMCID: PMC551684          DOI: 10.1002/j.1460-2075.1990.tb08128.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  46 in total

1.  Developmentally controlled and tissue-specific expression of unrearranged VH gene segments.

Authors:  G D Yancopoulos; F W Alt
Journal:  Cell       Date:  1985-02       Impact factor: 41.582

2.  Somatic diversification of the chicken immunoglobulin light chain gene is limited to the rearranged variable gene segment.

Authors:  C B Thompson; P E Neiman
Journal:  Cell       Date:  1987-02-13       Impact factor: 41.582

3.  Chance, necessity and antibody gene dynamics.

Authors:  C Coleclough
Journal:  Nature       Date:  1983 May 5-11       Impact factor: 49.962

4.  Unusual association of V, J and C regions in a mouse immunoglobulin lambda chain.

Authors:  B W Elliott; H N Eisen; L A Steiner
Journal:  Nature       Date:  1982-10-07       Impact factor: 49.962

5.  Novel kappa light-chain gene rearrangements in mouse lambda light chain-producing B lymphocytes.

Authors:  J Durdik; M W Moore; E Selsing
Journal:  Nature       Date:  1984 Feb 23-29       Impact factor: 49.962

6.  A new variable region in mouse immunoglobulin lambda light chains.

Authors:  P Sanchez; P A Cazenave
Journal:  J Exp Med       Date:  1987-07-01       Impact factor: 14.307

7.  Active lambda and kappa antibody gene rearrangement in Abelson murine leukemia virus-transformed pre-B cell lines.

Authors:  D M Persiani; J Durdik; E Selsing
Journal:  J Exp Med       Date:  1987-06-01       Impact factor: 14.307

8.  Allelic exclusion in transgenic mice that express the membrane form of immunoglobulin mu.

Authors:  M C Nussenzweig; A C Shaw; E Sinn; D B Danner; K L Holmes; H C Morse; P Leder
Journal:  Science       Date:  1987-05-15       Impact factor: 47.728

9.  Restricted association of V and J-C gene segments for mouse lambda chains.

Authors:  E B Reilly; B Blomberg; T Imanishi-Kari; S Tonegawa; H N Eisen
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

10.  Ordered rearrangement of immunoglobulin heavy chain variable region segments.

Authors:  F W Alt; G D Yancopoulos; T K Blackwell; C Wood; E Thomas; M Boss; R Coffman; N Rosenberg; S Tonegawa; D Baltimore
Journal:  EMBO J       Date:  1984-06       Impact factor: 11.598

View more
  28 in total

Review 1.  Role of B cell antigen receptor in regulation of V(D)J recombination and cell survival.

Authors:  D Nemazee
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

Review 2.  Receptor selection in B and T lymphocytes.

Authors:  D Nemazee
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 3.  Allelic exclusion of immunoglobulin genes: models and mechanisms.

Authors:  Christian Vettermann; Mark S Schlissel
Journal:  Immunol Rev       Date:  2010-09       Impact factor: 12.988

4.  The Igκ gene enhancers, E3' and Ed, are essential for triggering transcription.

Authors:  Xiaorong Zhou; Yougui Xiang; William T Garrard
Journal:  J Immunol       Date:  2010-11-12       Impact factor: 5.422

5.  Re-organization of the immunoglobulin kappa gene on both alleles is not an obligatory prerequisite for Ig lambda gene expression in human cells.

Authors:  H Abken; C Bützler
Journal:  Immunology       Date:  1991-12       Impact factor: 7.397

6.  Targeting Anti-Insulin B Cell Receptors Improves Receptor Editing in Type 1 Diabetes-Prone Mice.

Authors:  Rachel H Bonami; James W Thomas
Journal:  J Immunol       Date:  2015-10-02       Impact factor: 5.422

7.  Evidence for Ig Light Chain Isotype Exclusion in Shark B Lymphocytes Suggests Ordered Mechanisms.

Authors:  Anna Iacoangeli; Anita Lui; Ashley Haines; Yuko Ohta; Martin Flajnik; Ellen Hsu
Journal:  J Immunol       Date:  2017-07-31       Impact factor: 5.422

8.  Diverse immunoglobulin light chain organizations in fish retain potential to revise B cell receptor specificities.

Authors:  Ellen Hsu; Michael F Criscitiello
Journal:  J Immunol       Date:  2006-08-15       Impact factor: 5.422

9.  Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency.

Authors:  Jacob Hanna; Styliani Markoulaki; Patrick Schorderet; Bryce W Carey; Caroline Beard; Marius Wernig; Menno P Creyghton; Eveline J Steine; John P Cassady; Ruth Foreman; Christopher J Lengner; Jessica A Dausman; Rudolf Jaenisch
Journal:  Cell       Date:  2008-04-18       Impact factor: 41.582

10.  Distinct roles for E12 and E47 in B cell specification and the sequential rearrangement of immunoglobulin light chain loci.

Authors:  Kristina Beck; Mandy M Peak; Takayuki Ota; David Nemazee; Cornelis Murre
Journal:  J Exp Med       Date:  2009-09-14       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.